Approval · Notice of Compliance 4899 · 1995
BAMBEC: Notice of Compliance 4899
Issued February 7, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4899
- Date
- February 7, 1995
- Company
- Astra Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAMBEC | 02148641 | — |
| BAMBEC | 02148668 | — |
Medicinal ingredients
- BAMBUTEROL HCL 10 MG per TAB
- BAMBUTEROL HCL 20 MG per TAB